Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00582322 · ClinicalTrials.gov registry record
Genetic Studies in Breast Cancer
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 483
- Enrollment target
NCT00582322: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00582322 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 483 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00582322 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 483 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the specific genetic alterations associated with breast cancer. This will leat to a better understanding of the genetic causes of breast cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 483 participants |
| Start Date | 1992-02 |
| Est. Completion | 2009-07 |
What the finished NCT00582322 record still lists
NCT00582322 is an observational study that tracks outcomes without assigning an intervention. The registered 483 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00582322 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00582322 about?
NCT00582322 is a clinical study titled "Genetic Studies in Breast Cancer". The purpose of this study is to determine the specific genetic alterations associated with breast cancer. This will leat to a better understanding of the genetic causes of breast cancer.
What is the current status of trial NCT00582322?
This trial is currently completed. The enrollment target is 483 participants. The study started on 1992-02. Estimated completion is 2009-07.
Who is sponsoring clinical trial NCT00582322?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02871726 · 483 participants · NA
Transrectal Ultrasound Robot-Assisted Prostate Biopsy
- NCT05421741 · 484 participants · Phase 4
Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
- NCT04449458 · 482 participants · NA
The Positively Quit Trial for Smoking Cessation
- NCT07079631 · 482 participants · Phase 1
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia